Mark Powell
7Patents
1h-index
22Co-inventors
47Inventor score
Filing activity: Jul 10, 2002 → May 23, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7579356B2 | Thia-tetraazaacenaphthylene kinase inhibitors | Human Necessities | 9 | Expired |
| US6890725B2 | Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use | Physics | 1 | Expired |
| US6929923B2 | Modulators of leukocyte activation, BIC compositions and methods of use | Physics | 1 | Expired |
| US8748624B2 | Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists | Human Necessities | 1 | Active |
| US7067266B2 | Modulators of leukocyte activation, Hck compositions and methods of use | Physics | 0 | Expired |
| US7427625B2 | Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7371537B2 | Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.